- Home
- SCLX vs VANI Comparison
SCLX vs VANI Comparison
Compare SCLX & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- VANI
- Stock Information
- Founded
- SCLX 2011
- VANI 1998
- Country
- SCLX United States
- VANI United States
- Employees
- SCLX N/A
- VANI N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SCLX Health Care
- VANI Health Care
- Exchange
- SCLX Nasdaq
- VANI Nasdaq
- Market Cap
- SCLX 72.5M
- VANI 69.9M
- IPO Year
- SCLX N/A
- VANI 2014
- Fundamental
- Price
- SCLX $0.45
- VANI $1.20
- Analyst Decision
- SCLX Strong Buy
- VANI Strong Buy
- Analyst Count
- SCLX 3
- VANI 1
- Target Price
- SCLX $11.33
- VANI $3.00
- AVG Volume (30 Days)
- SCLX 184.3K
- VANI 134.7K
- Earning Date
- SCLX 03-11-2025
- VANI 11-13-2024
- Dividend Yield
- SCLX N/A
- VANI N/A
- EPS Growth
- SCLX N/A
- VANI N/A
- EPS
- SCLX N/A
- VANI N/A
- Revenue
- SCLX $55,152,000.00
- VANI N/A
- Revenue This Year
- SCLX $32.77
- VANI N/A
- Revenue Next Year
- SCLX $50.71
- VANI N/A
- P/E Ratio
- SCLX N/A
- VANI N/A
- Revenue Growth
- SCLX 9.41
- VANI N/A
- 52 Week Low
- SCLX $0.38
- VANI $1.01
- 52 Week High
- SCLX $2.63
- VANI $7.80
- Technical
- Relative Strength Index (RSI)
- SCLX 42.08
- VANI 43.85
- Support Level
- SCLX $0.40
- VANI $1.17
- Resistance Level
- SCLX $0.53
- VANI $1.23
- Average True Range (ATR)
- SCLX 0.05
- VANI 0.05
- MACD
- SCLX 0.01
- VANI 0.00
- Stochastic Oscillator
- SCLX 47.59
- VANI 31.58
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.